Annuncio pubblicitario
Italia markets closed
  • FTSE MIB

    33.629,21
    -107,19 (-0,32%)
     
  • Dow Jones

    38.675,68
    +450,02 (+1,18%)
     
  • Nasdaq

    16.156,33
    +315,37 (+1,99%)
     
  • Nikkei 225

    38.236,07
    -37,98 (-0,10%)
     
  • Petrolio

    77,99
    -0,96 (-1,22%)
     
  • Bitcoin EUR

    59.383,74
    +1.020,20 (+1,75%)
     
  • CMC Crypto 200

    1.359,39
    +82,41 (+6,45%)
     
  • Oro

    2.310,10
    +0,50 (+0,02%)
     
  • EUR/USD

    1,0765
    +0,0038 (+0,36%)
     
  • S&P 500

    5.127,79
    +63,59 (+1,26%)
     
  • HANG SENG

    18.475,92
    +268,79 (+1,48%)
     
  • Euro Stoxx 50

    4.921,48
    +30,87 (+0,63%)
     
  • EUR/GBP

    0,8577
    +0,0023 (+0,27%)
     
  • EUR/CHF

    0,9735
    -0,0024 (-0,25%)
     
  • EUR/CAD

    1,4726
    +0,0064 (+0,44%)
     

Ensurge Micropower ASA Presentation and Q&A session

Ensurge Micropower ASA
Ensurge Micropower ASA

With reference to the announcement 27 September 2023, and the presentation held Thursday 28 September 2023, we have
attached an updated Investor presentation.

About Ensurge Micropower

Ensurge is Energizing Innovation(TM) with the first ultrathin, flexible, reliable, and fundamentally safe solid-state lithium microbattery for the 1 to 100 milliampere-hour (mAh) class of wearable devices, connected sensors, and beyond. The innovative Ensurge Microbattery enables energy-dense rechargeable products that are ideal for form-factor-constrained applications including hearables (hearing aids and wireless headphones), digital and health wearables, sports and fitness devices, and IoT sensor solutions that use energy harvesting to power everyday things. The company's state-of-the-art manufacturing facility, located in the heart of Silicon Valley, combines patented process technology and materials innovation with the scale of roll-to-roll production methods to bring the advantages of Ensurge technology to established and expanding markets.

Contact: 
Terje Rogne, Chairman of the BoD 
Phone: +47 472 02 200

Attachment